Immunization of knock-out α/β interferon receptor mice against high lethal dose of Crimean-Congo hemorrhagic fever virus with a cell culture based vaccine.

Crimean-Congo hemorrhagic fever (CCHF) is an acute tick-borne zoonotic disease. The disease has been reported in many countries of Africa, Asia, the Middle East, and in Eurasia. During the past decade, new foci of CCHF have emerged in the Balkan Peninsula, southwest Russia, the Middle East, western...

Full description

Saved in:
Bibliographic Details
Main Authors: Nurettin Canakoglu (Author), Engin Berber (Author), Sukru Tonbak (Author), Mustafa Ertek (Author), Ibrahim Sozdutmaz (Author), Munir Aktas (Author), Ahmet Kalkan (Author), Aykut Ozdarendeli (Author)
Format: Book
Published: Public Library of Science (PLoS), 2015-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8fdde1e42f5046a28fc715e7787617aa
042 |a dc 
100 1 0 |a Nurettin Canakoglu  |e author 
700 1 0 |a Engin Berber  |e author 
700 1 0 |a Sukru Tonbak  |e author 
700 1 0 |a Mustafa Ertek  |e author 
700 1 0 |a Ibrahim Sozdutmaz  |e author 
700 1 0 |a Munir Aktas  |e author 
700 1 0 |a Ahmet Kalkan  |e author 
700 1 0 |a Aykut Ozdarendeli  |e author 
245 0 0 |a Immunization of knock-out α/β interferon receptor mice against high lethal dose of Crimean-Congo hemorrhagic fever virus with a cell culture based vaccine. 
260 |b Public Library of Science (PLoS),   |c 2015-03-01T00:00:00Z. 
500 |a 1935-2727 
500 |a 1935-2735 
500 |a 10.1371/journal.pntd.0003579 
520 |a Crimean-Congo hemorrhagic fever (CCHF) is an acute tick-borne zoonotic disease. The disease has been reported in many countries of Africa, Asia, the Middle East, and in Eurasia. During the past decade, new foci of CCHF have emerged in the Balkan Peninsula, southwest Russia, the Middle East, western China, India, Africa, and Turkey. CCHF virus produces severe hemorrhagic manifestations in humans with fatality rates up to 30%. Vaccine development efforts have been significantly hampered by a lack of animal models and therefore, no protective vaccine has been achieved. Lately, IFN α/β receptor deficient (IFNAR-/-) mice have been established as a novel small animal model of CCHF virus infection. In the present study, we found that IFNAR-/- mice highly susceptible to CCHF virus Turkey-Kelkit06 strain. Immunization with the cell culture based vaccine elicited a significant level of protection against high dose challenge (1,000 PPFU) with a homologous CCHF virus in IFNAR-/- mice. 
546 |a EN 
690 |a Arctic medicine. Tropical medicine 
690 |a RC955-962 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n PLoS Neglected Tropical Diseases, Vol 9, Iss 3, p e0003579 (2015) 
787 0 |n http://europepmc.org/articles/PMC4356576?pdf=render 
787 0 |n https://doaj.org/toc/1935-2727 
787 0 |n https://doaj.org/toc/1935-2735 
856 4 1 |u https://doaj.org/article/8fdde1e42f5046a28fc715e7787617aa  |z Connect to this object online.